AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
How Can We Reduce Risks in Biotechnology?
Jonas: We need to take a look at boutacnology more broadly and really think about how can we reduce risks across o our portfolio. One thing that i think would be helpful here is to move away from only deciding which project is going to be founded based on the promise, but rather move towards comparative risk benefit assessment. You might preferentially find non viral approaches that do not advance viral engineering over approaches sat involve viral engineering.